Older Adults Accessing HIV Care and Treatment and Adherence in the IeDEA Central Africa Cohort
Table 2
Adjusted1 odds ratios and 95% confidence intervals for the association of medication adherence2 and age.
Variable
Medication adherence Odds ratio
95% confidence interval
P value
Main effect variable
Age
18–49 years
Ref
<0.001
50+ years
1.59*
(1.21, 2.09)
Covariates
Country
DRC
Ref
<0.001
Burundi
2.23*
(1.57, 3.15)
Cameroon
1.98*
(1.60, 2.46)
Marital status
Single
Ref
0.848
Divorced
1.05
(0.76, 1.46)
Widowed
1.11
(0.85, 1.44)
Married/living together (includes monogamous and polygamous marriage)
1.09
(0.88, 1.36)
Sex
Female
Ref
0.569
Male
0.95
(0.78, 1.15)
Employment status
No paid employment
Ref
0.813
Paid employment
1.02
(0.86, 1.22)
Heavy drinking
Yes
Ref
<0.001
No
1.40*
(1.15, 1.70)
Education level
Secondary/University
Ref
0.216
Primary
0.94
(0.79, 1.12)
No formal education
0.72
(0.50, 1.05)
Clinical stage (WHO) at enrollment into IeDEA database
I/II
Ref
0.774
III/IV
0.97
(0.82, 1.17)
Length of time on ARVs
<6 months
Ref
<0.001
6–24 months
0.69*
(0.53, 0.89)
>24 months
1.12
(0.87, 1.45)
Not on ARVs
2.05*
(1.51, 2.78)
*
. 1Adjusted for country, marital status, gender, employment status, heavy drinking, education, clinical stage at enrollment into IeDEA database, and length of time on ARVs. 2Nonadherence was defined as missed doses of ART or other HIV-related medications (most commonly cotrimoxazole prophylaxis and, to a lesser extent, TB prophylaxis and TB treatment) for two or more consecutive days in the past 30 days.
